(ONCT) |
| 0 (0%) 10-10 11:57 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 0.62 |
| Resistance 1: | 0.53 |
| Pivot price: | 0.53 |
| Support 1: | 0.53 |
| Support 2: | 0.53 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 482.132 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -1.00 |
| Return on Assets (ttm) | 757.3 |
| Return on Equity (ttm) | -76.4 |
Company news
Tue, 01 Jul 2025
Oncternal's $68M Asset Sale Deal: Biotech Company Sells Cancer Programs Before Complete Shutdown - Stock Titan
Tue, 01 Jul 2025
ROR deal: Oncternal sells cancer assets to mystery biotech for $3M, winds down operations - Fierce Biotech
Fri, 07 Mar 2025
From Nasdaq to Dark: What's Next for Oncternal After March 2025 Delisting? - Stock Titan
Thu, 23 Jan 2025
ONCT stock price: Oncternal stock crashes by 60% after layoffs - Markets.com
Mon, 25 Nov 2024
Oncternal shares to be delisted from Nasdaq - Investing.com
Thu, 07 Nov 2024
Phase 1/2 trial of ONCT-534 in mCRPC has been terminated - Urology Times
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
